Echo Street Capital Management’s Quest Diagnostics DGX Stock Holding History

Echo Street Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,057	Closed	-$373K	–	120
2023 Q3	$373K	Buy	3,057 +587	+24%	+$78.2K	﹤0.01%	334
2023 Q2	$347K	Buy	+2,470	New	+$341K	﹤0.01%	354
2022 Q3	–	Sell	-2,776	Closed	-$369K	–	582
2022 Q2	$369K	Sell	2,776 -2,233	-45%	-$304K	﹤0.01%	378
2022 Q1	$686K	Sell	5,009 -2,544	-34%	-$355K	﹤0.01%	326
2021 Q4	$1.31M	Sell	7,553 -1,259	-14%	-$192K	0.01%	201
2021 Q3	$1.28M	Buy	8,812 +6,889	+358%	+$1.01M	0.01%	206
2021 Q2	$254K	Buy	+1,923	New	+$252K	﹤0.01%	513
2021 Q1	–	Sell	-4,466	Closed	-$532K	–	530
2020 Q4	$532K	Buy	+4,466	New	+$544K	0.01%	252
2020 Q3	–	Sell	-7,887	Closed	-$899K	–	181
2020 Q2	$899K	Buy	+7,887	New	+$837K	0.01%	277

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Echo Street Capital Management's DGX Position: Q4 2023 in Review

Echo Street Capital Management sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 3,057 shares — an estimated $373K sold.

Echo Street Capital Management first reported a position in DGX in Q2 2020 and held it in 9 quarters. The position peaked at $1.31M in Q4 2021. 827 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

Echo Street Capital Management reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
Echo Street Capital Management sold 3,057 Quest Diagnostics shares in Q4 2023, an estimated $373K.
Echo Street Capital Management first reported a position in Quest Diagnostics in Q2 2020 and held it in 9 quarters.
Echo Street Capital Management's Quest Diagnostics position peaked at $1.31M in Q4 2021.
827 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on Echo Street Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.